Avalon Trust’s AstraZeneca AZN Stock Holding History

Avalon Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$147K	Hold	774	–	–	0.01%	173
2026 Q1	$153K	Buy	774 +599	+342%	+$115K	0.01%	174
2025 Q4	$32.2K	Hold	175	–	–	﹤0.01%	322
2025 Q3	$26.9K	Hold	175	–	–	﹤0.01%	374
2025 Q2	$24.5K	Sell	175 -268	-60%	-$37.6K	﹤0.01%	312
2025 Q1	$65.1K	Buy	443 +268	+153%	+$38.8K	0.01%	219
2024 Q4	$22.9K	Sell	175 -600	-77%	-$84K	﹤0.01%	286
2024 Q3	$121K	Sell	775 -600	-44%	-$96.9K	0.01%	152
2024 Q2	$214K	Hold	1,375	–	–	0.02%	124
2024 Q1	$186K	Sell	1,375 -400	-23%	-$53K	0.02%	137
2023 Q4	$239K	Sell	1,775 -88	-5%	-$11.4K	0.02%	114
2023 Q3	$252K	Hold	1,863	–	–	0.03%	104
2023 Q2	$267K	Hold	1,863	–	–	0.02%	112
2023 Q1	$259K	Buy	+1,863	New	+$251K	0.03%	109

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Avalon Trust's AZN Position: Q2 2026 in Review

Avalon Trust held its AstraZeneca (AZN) position steady in Q2 2026 at 774 shares worth $147K. The position accounts for 0.01% of the portfolio, ranked #173.

Avalon Trust first reported a position in AZN in Q1 2023 and has held it in 14 quarters since. The position peaked at $267K in Q2 2023. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Avalon Trust held 774 shares of AstraZeneca worth $147K as of Q2 2026.
Avalon Trust left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.01% of Avalon Trust's portfolio in Q2 2026, its #173 holding.
Avalon Trust first reported a position in AstraZeneca in Q1 2023 and has held it in 14 quarters since.
Avalon Trust's AstraZeneca position peaked at $267K in Q2 2023.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.